Navigation Links
Mylan to Host Investor Day on Feb. 21, 2012, in New York City
Date:1/24/2012

NEW YORK, Jan. 24, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) will host an Investor Day on Feb. 21, in New York City.   Robert J. Coury, Mylan's executive chairman; Heather Bresch, chief executive officer; Rajiv Malik, president; Hal Korman, chief operating officer; John Sheehan, chief financial officer; and John Thievon, president of Dey Pharma,  will present the company's financial guidance for 2012 and an overview of the company's strategic vision and growth strategy for 2013 and beyond.  They will be joined by Tony Mauro, president of North America, and Didier Barret, president of Mylan's Europe, Middle East and Africa operations, for a question and answer session.

The presentations will be broadcast live via webcast beginning at 1 p.m. ET.  The meeting is expected to conclude by 5 p.m. ET. 

The company will issue its fourth quarter and full-year 2011 earnings results before the market opens on Feb. 21.

To access the live webcast and view the accompanying slide presentations, visit the Investor Relations section of Mylan's website, at http://investor.mylan.com, at least 15 minutes before the presentation is scheduled to begin; click on the webcast icon to register and download or install any necessary software.  If you are unable to view the live webcast, a replay will be available for 30 days on Mylan's website after the event's conclusion.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Launches Innovative Version of Antiepileptic Drug Levetiracetam
2. Mylan Launches First Generic Version of Teveten® Tablets
3. Mylan Receives Approval for First-to-File Generic Keppra XR® Extended-Release Tablets
4. Mylan Receives WHO Approval for Innovative Second-Line-in-a-Box HIV/AIDS Treatment
5. Mylan Launches Generic Version of Toprol-XL® Tablets
6. Mylan Names John Thievon President of Dey Pharma
7. Mylan Launches Generic Version of Cyklokapron® Injection
8. Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS
9. Mylan Launches Generic Version of Caduet® Tablets
10. Mylan Confirms First-to-File Patent Challenge Relating to Generess™ Fe
11. Mylan Committed to Expanding Access in Developing Countries to High Quality, Affordable HIV/AIDS Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... the latest in wound care advancements to physician colleagues, skilled nursing facility medical ... titled, "Navigating the Treacherous Waters of Wound Care." , "At many of these ...
Breaking Medicine News(10 mins):